A community from Nature Neuroscience
Menu

Nature Neuroscience - key issues in Alzheimer's Disease

  • Sign In

Cookies

We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.

You can consent to the use of such technologies by closing this notice.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.

  • Forum Policy
  • Website Terms of Use
  • Online Privacy Notice
  • Cookie Policy
  • Report Content
Copyright © 2022 Macmillan Publishers Limited, part of Springer Nature All rights reserved. Powered by Zapnito.
Nature Neuroscience - key issues in Alzheimer's Disease
Nature Neuroscience - key issues in Alzheimer's Disease
  • Home
  • Channels
    • Back
    • Beyond Aβ and tau: other toxic insults and AD pathology
    • Changes in network function during AD
    • Intracellular Aβ and APP processing
    • Questions from the audience: mechanisms, models and therapies.
    • The amyloid hypothesis​​
    • The value of AD models
  • Forum
  • People
    • Back
    • Editors
    • Panelists
    • Members
  • About This Forum
  • Forum Guidelines
  • Top Tips
  • Account
  • Sign In
  • Social
  • Twitter

If you are a registered user on Nature Neuroscience - key issues in Alzheimer's Disease, please sign in.

Sign in to Nature Neuroscience - key issues in Alzheimer's Disease

Lost your password? Resend confirmation

Nature Neuroscience presents a forum on critical issues facing Alzheimer's Disease research today. In a panel discussion, available to view on this site, key researchers in the field considered the support for the pathogenic mechanisms that have been proposed to date, the pros and cons of the current preclinical animal model systems, and the obstacles that the field faces in translating basic discoveries to the clinic. This community has been created to continue this discussion online, allowing for the exchange of ideas between community members. The featured articles in this forum have been made freely available until April 30, 2016 thanks to generous support from Eli Lilly and Company and vTv Therapeutics. Nature Neuroscience is entirely responsible for the selection of the featured content.